GX Acquisition Corp.
Completed
Follow
Detailed Information
Information on this SPAC.
- Sponsors
- IPO Size
- $250M
- Underwriters
- SEC Filings
- 1752828
- Public Embarc Page
- https://embarc.com/capital/spac/1752828/GXGX/gx-acquisition
- IPO Ticker
- GXGX
SPAC Leadership
Information on the SPAC leadership.
- Co-Chairman and Chief Executive OfficerJay R. Bloom
- Co Chairman and Chief Executive OfficerDean C. Kehler
- Vice President of AcquisitionsMichael G. Maselli
- Chief Financial OfficerAndrea J. Kellett
- DirectorHillel Weinberger
- DirectorMarc Mazur
- DirectorPaul S. Levy
Target Information
Information on the SPAC target for merger.
- Company
- Celularity
- Presentation
- Investor Presentation (SEC) on 2021-04-20
- Description
- Celularity is "a clinical-stage biotechnology company leading the next evolution in cellular medicine with the development of off-the-shelf allogeneic therapies derived from the postpartum human placenta."